Response to Proposal for a Regulation of the European Parliament and of the Council amending Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnostic medical devices as regards simplification and burden reduction

6 Oct 2025

Meeting with Jana Dabbelt (Cabinet of Commissioner Olivér Várhelyi)

25 Sept 2025 · future of healthcare financing within a solidarity-based social security system

Response to Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

11 Jun 2025

Response to Evaluation of Directive 2014/23/EU on the award of concessions contracts, Directive 2014/24/EU on public procurement, and Directive 2014/25/EU on procurement by entities operating in the water, energy, transport and postal services sectors

7 Mar 2025

Meeting with Evelyn Regner (Member of the European Parliament)

14 Feb 2024 · General Exchange of Views

Meeting with Evelyn Regner (Member of the European Parliament)

29 Jan 2024 · General Exchange of Views

Meeting with Günther Sidl (Member of the European Parliament)

31 May 2023 · Pharma Legislation/Arzneimittelgesetz

Meeting with Jens Geier (Member of the European Parliament)

17 May 2023 · Exchange on current pharma legislation (staff level)

Meeting with Joost Korte (Director-General Employment, Social Affairs and Inclusion)

16 Mar 2023 · Digitization of social security systems

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the European Health Data Space

28 Jul 2022

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on harmonised rules on fair access to and use of data (Data Act)

13 May 2022

Response to Revision of Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC)

22 Feb 2022

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on improving working conditions in platform work

14 Feb 2022

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EU) No 910/2014 as regards establishing a framework for a European Digital Identity

1 Sept 2021

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Response to Report from the Commission to the EP and Council on the operation and performance of the Directive 2011/24/EU on the application of patient rights in cross-border healthcare foreseen under Article 17(1) and Article 20(1) & (2) of Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011

11 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on European data governance (Data Governance Act)

5 Feb 2021

Response to Proposal for Regulation [tbc] on the European Health Data Space, digital health services and products and the use of new technologies, including artificial intelligence (AI) in health

1 Feb 2021

Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products

6 Jan 2021

Response to Green Paper on Ageing

14 Dec 2020

Meeting with Christoph Nerlich (Cabinet of Commissioner Nicolas Schmit), Eugenia Dumitriu-Segnana (Cabinet of Commissioner Nicolas Schmit)

20 Oct 2020 · implementation of the European Pillar of Social Rights, exchange concerning the circulating idea of a European Social Security Number

Meeting with Ines Prainsack (Cabinet of Commissioner Stella Kyriakides), Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

14 Oct 2020 · Presentation of position by the Austrian Social Insurance on the Pharmaceutical Strategy and exchange of views.

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions "Making the most of EU’s innovative potential - An Intellectual Property action plan in support of the EU’s industrial competitiveness"

14 Aug 2020

Response to Legislative framework for the governance of common European data spaces

30 Jul 2020

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

6 Jul 2020